title: Synthesis and antiproliferative properties of N3/8-disubstituted 3,8-diazabicyclo[3.2.1]octane analogues of 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridin-4-yl]methyl-piperazine.
abstract: A series of novel N(3/8)-disubstituted-3,8-diazabicyclo[3.2.1]octanes in order to improve the in vitro activity of the prototype 3,8-bis[2-(3,4,5-trimethoxyphenyl)pyridyl-4-yl)methylpiperazine (1) were synthesized and evaluated by assays of growth inhibition against several tumor cell lines. Compounds 2a,b,f and m demonstrated not only growth-inhibitory activities against leukemia cancer cells, but also fairly good activities against the growth of certain solid tumors. Among them, 2a is the most potent one with IC(50) values in the low micromolar range. Moreover, compound 2a has been selected for in vitro testing on MCF-7 cell to evaluate the mode of action of this lead compound.
authors.affiliation: Dipartimento di Scienze Farmaceutiche, Università di Salerno, Via ponte don Melillo, 84084 Fisciano (SA), Italy. rfilosa@unisa.it
authors.forename: Rosanna
authors.initials: R
authors.lastname: Filosa
authors.forename: Antonella
authors.initials: A
authors.lastname: Peduto
authors.forename: Paolo
authors.initials: P
authors.lastname: de Caprariis
authors.forename: Carmela
authors.initials: C
authors.lastname: Saturnino
authors.forename: Michela
authors.initials: M
authors.lastname: Festa
authors.forename: Antonello
authors.initials: A
authors.lastname: Petrella
authors.forename: Amedeo
authors.initials: A
authors.lastname: Pau
authors.forename: Gérard Aimé
authors.initials: GA
authors.lastname: Pinna
authors.forename: Paolo
authors.initials: P
authors.lastname: La Colla
authors.forename: Bernardetta
authors.initials: B
authors.lastname: Busonera
authors.forename: Roberta
authors.initials: R
authors.lastname: Loddo
mesh_terms: D000478:Alkylation; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000138:chemical synthesis* / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000187:drug effects / Q000648:ultrastructure; D049109:Cell Proliferation / Q000187:drug effects; D004396:Coloring Agents; D004171:Diploidy; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007202:Indicators and Reagents; D008872:Microwaves; D010879:Piperazines / Q000138:chemical synthesis* / Q000494:pharmacology*; D011419:Propidium; D011725:Pyridines / Q000138:chemical synthesis* / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: C519544:3,8-bis(2-(3,4,5-trimethoxyphenyl)pyridin-4-yl)methyl-piperazine; D000970:Antineoplastic Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D004396:Coloring Agents; D007202:Indicators and Reagents; D010879:Piperazines; D011725:Pyridines; D011419:Propidium